Boston Scientific has initiated the limited market release of the Seismiq intravascular lithotripsy (IVL) system, marking the ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

This week's Medtech in a Minute features news about Boston Scientific and a potentially dangerous chemical used in IV bags ...

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we ...

Boston Scientific announced it has received CE Mark approval for the company’s Embold detachable coil system, which is a ...

Boston Scientific is planning a new 300,000-square-foot lab and office building in Maple Grove, expanding its Arbor Lakes ...

Penumbra’s stock was up about 12% after the deal was announced Thursday morning.

Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden ...

By Mariam Sunny and Mrinalika Roy Jan 15 (Reuters) - Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion ...

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...